Treatment of PCSCs with metformin could induce the re-expression of miR-200c which is frequently lost in PC and reduce the expression of the PC stemness factors CD44, EpCAM, EZH2, NOTCH-1, NANOG, and OCT4 [125]. Here, CD44 is linked to pachyonychia congenita.